MXCT – maxcyte, inc. (US:NASDAQ)
Stock Stats
News
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
MaxCyte, Inc. (NASDAQ: MXCT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $11.00 price target on the stock.
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth [Yahoo! Finance]
Form 10-Q MAXCYTE, INC. For: Mar 31
Form 8-K MAXCYTE, INC. For: May 07
Form ARS MAXCYTE, INC. For: Dec 31
Form DEF 14A MAXCYTE, INC. For: Jun 11
Form 4 MAXCYTE, INC. For: Mar 26 Filed by: Johnston John Joseph
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.